Search details
1.
The first step of peptide selection in antigen presentation by MHC class I molecules.
Proc Natl Acad Sci U S A
; 112(5): 1505-10, 2015 Feb 03.
Article
in English
| MEDLINE | ID: mdl-25605945
2.
Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.
J Immunol
; 193(10): 4803-13, 2014 Nov 15.
Article
in English
| MEDLINE | ID: mdl-25311806
3.
Development of a hypersensitive periodate-cleavable amino acid that is methionine- and disulfide-compatible and its application in MHC exchange reagents for T cell characterisation.
Chembiochem
; 14(1): 123-31, 2013 Jan 02.
Article
in English
| MEDLINE | ID: mdl-23280887
4.
Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.
Proc Natl Acad Sci U S A
; 105(10): 3825-30, 2008 Mar 11.
Article
in English
| MEDLINE | ID: mdl-18308940
5.
Improved single-chain transactivators of the Tet-On gene expression system.
BMC Biotechnol
; 7: 6, 2007 Jan 19.
Article
in English
| MEDLINE | ID: mdl-17239234
6.
Chemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of Immunodominance.
PLoS One
; 11(6): e0156462, 2016.
Article
in English
| MEDLINE | ID: mdl-27333291
7.
Technologies for MHC class I immunoproteomics.
J Proteomics
; 73(10): 1945-53, 2010 Sep 10.
Article
in English
| MEDLINE | ID: mdl-20546957
8.
Delivery of 2-5A cargo into living cells using the Tat cell penetrating peptide: 2-5A-tat.
Bioorg Med Chem
; 14(23): 7862-74, 2006 Dec 01.
Article
in English
| MEDLINE | ID: mdl-16908165
Results
1 -
8
de 8
1
Next >
>>